CACNA1D mutations have previously been associated with primary aldosteronism, seizures, and neurologic abnormalities (PASNA; OMIM #615474), thus suggesting a disease spectrum that may include CHI with reduced penetrance. This evidence concerns the gene CACNA1D and primary aldosteronism.